电针疗法通过调节Sirt1和Nrf2-ARE通路来缓解中风后的失眠
Yiming Wang1, Yifei Chen2, Jianbo Yang3
1The Fourth Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region Chinese Medicine Hospital, Urumqi, Xinjiang, China.
Neuromolecular medicine
|May 17, 2025
概括
电针 (EA) 通过激活Nrf2-ARE通路,改善了中风后失眠 (PSI) 的睡眠质量. 这种治疗减少了炎症,氧化应激和天体细胞损伤,为PSI患者提供了一种新的治疗方法.
科学领域:
- 神经科学是一个神经科学.
- 综合医学是一个整体的医学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 脑卒中后失眠 (PSI) 严重损害了患者的生活质量.
- 电针 (EA) 对PSI有希望,但其机制尚不清楚.
- 了解EA在PSI中的作用对于开发有效的治疗方法至关重要.
研究的目的:
- 研究EA在中风后失眠的治疗机制.
- 探索EA对神经递质,炎症和PSI中的氧化应激的影响.
- 阐明Sirtuin 1 (Sirt1) 和Nrf2-ARE通路在EA对PSI的疗效中的作用.
主要方法:
- 使用了PSI的临床样本和老鼠模型.
- 评估睡眠质量,神经递质水平 (5-HT, γ-GABA) 和抗氧化剂标志物.
- 分析了促炎因素 (IL-6,TNF-α),星球细胞损伤,Sirt1和Nrf2-ARE通路的激活.
主要成果:
- EA治疗改善了PSI的睡眠质量,神经递质水平和抗氧化能力.
- EA显著降低了炎症,IL-6,TNF-α和天体细胞损伤.
- EA提高了Sirt1的调节,抑制了亡,并激活了Nrf2-ARE通路,抵消了PSI引起的有害影响.
结论:
- 通过调节神经递质和减少炎症和氧化应激,EA提高了PSI的睡眠质量.
- EA的治疗作用通过Sirt1和Nrf2-ARE通路进行介导.
- 脑电阻是治疗中风后失眠的有前途的治疗策略.
关键词:
细胞灭亡 (apoptosis) 是一种死亡的过程.炎症 炎症是一种炎症.Nrf2-ARE 途径通过氧化应激是一种氧化应激.脑卒中后的失眠问题在 Sirtuin 11 里面,我们可以找到 Sirtuin 11.更多相关视频
03:26Acupuncture Treatment in a Mouse Model of Chronic Hypoxia-Induced Cognitive Dysfunction
Published on: December 8, 2023
06:45Effect of Yi-Nao-Jie-Yu Prescription on Post-Stroke Depression in Rats using Middle Cerebral Artery Occlusion Combined with Behavioral Restraint
Published on: January 9, 2026
相关概念视频
01:19Management of Insomnia
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...